- Home
- ARMP vs ELBM Comparison
ARMP vs ELBM Comparison
Compare ARMP & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- ELBM
- Stock Information
- Founded
- ARMP N/A
- ELBM 2011
- Country
- ARMP United States
- ELBM Canada
- Employees
- ARMP N/A
- ELBM N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- ELBM Industrial Machinery/Components
- Sector
- ARMP Health Care
- ELBM Miscellaneous
- Exchange
- ARMP Nasdaq
- ELBM Nasdaq
- Market Cap
- ARMP 125.7M
- ELBM 119.9M
- IPO Year
- ARMP N/A
- ELBM N/A
- Fundamental
- Price
- ARMP $5.73
- ELBM $0.93
- Analyst Decision
- ARMP Strong Buy
- ELBM Strong Buy
- Analyst Count
- ARMP 1
- ELBM 2
- Target Price
- ARMP $9.00
- ELBM $2.20
- AVG Volume (30 Days)
- ARMP 759.0K
- ELBM 22.5M
- Earning Date
- ARMP 11-07-2025
- ELBM 11-14-2025
- Dividend Yield
- ARMP N/A
- ELBM N/A
- EPS Growth
- ARMP N/A
- ELBM N/A
- EPS
- ARMP N/A
- ELBM N/A
- Revenue
- ARMP $6,868,000.00
- ELBM N/A
- Revenue This Year
- ARMP $8.43
- ELBM N/A
- Revenue Next Year
- ARMP N/A
- ELBM N/A
- P/E Ratio
- ARMP N/A
- ELBM N/A
- Revenue Growth
- ARMP 84.67
- ELBM N/A
- 52 Week Low
- ARMP $0.90
- ELBM $0.77
- 52 Week High
- ARMP $16.34
- ELBM $8.70
- Technical
- Relative Strength Index (RSI)
- ARMP 63.43
- ELBM 43.26
- Support Level
- ARMP $4.65
- ELBM $0.97
- Resistance Level
- ARMP $6.36
- ELBM $1.12
- Average True Range (ATR)
- ARMP 1.34
- ELBM 0.22
- MACD
- ARMP 0.01
- ELBM -0.14
- Stochastic Oscillator
- ARMP 22.25
- ELBM 0.13
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.